Continue to access content Select an option below: This content requires an account. Create Account Already have an account? Sign In

The current standard of care for patients with β-thalassemia — lifelong, regular red-cell transfusions and iron chelation — is associated with a risk of serious complications. New research findings are summarized in a short video.